References
- Adeshara, K.A., Diwan, A.G., and Tupe, R.S., 2016. Diabetes and complications: cellular signaling pathways, current understanding and targeted therapies. Current drug targets, 17 (11), 1309–1328.
- Agarwal, P., 2013. Management of diabetic kidney disease: recent advances. Indian journal of endocrinology and metabolism, 17 (7), 55–58.
- Balbi, A.P., et al., 2009. Roles of mitogen-activated protein kinases and angiotensin II in renal development. Brazilian journal of medical and biological research = Revista Brasileira de Pesquisas Medicas e Biologicas, 42 (1), 38–43.
- Basi, S., et al., 2008. Micro albuminuria in Type 2 diabetes and hypertension: a marker, treatment target, or innocent bystander? Diabetes care, 31 (Supplement 2), S194–S201.
- Bouvet, B.R., et al., 2014. Evaluation of urinary N-acetyl-beta-D-glucosaminidase as a marker of early renal damage in patients with type 2 diabetes mellitus. Arquivos brasileiros de endocrinologia & metabologia, 58 (8), 798–801.
- Brahmanaidu, P., et al., 2016. Effects of S-allylcysteine on biomarkers of the polyol pathway in rats with type 2 diabetes. Canadian journal of diabetes, 40 (5), 442–448.
- Brahmanaidu, P., et al., 2017. Reversal of endothelial dysfunction in aorta of streptozotocin-nicotinamide-induced type-2 diabetic rats by S-Allylcysteine. Molecular and cellular biochemistry, 432 (1-2), 25–32.
- Burns, N., and Gold, B., 2007. The effect of 3-methyladenine DNA glycosylase-mediated DNA repair on the induction of toxicity and diabetes by the beta-cell toxicant streptozotocin. Toxicological sciences: an official journal of the society of toxicology, 95 (2), 391–400.
- Chang, A.S., et al., 2016. Transforming growth factor-β1 and diabetic nephropathy. American journal of physiology renal physiology, 310 (8), F689–696.
- Chou, K.M., et al., 2013. Clinical value of NGAL, L-FABP and albuminuria in predicting GFR decline in type 2 diabetes mellitus patients. PLoS One, 8 (1), e54863.
- Dounousi, E., et al., 2015. Improvements in the management of diabetic nephropathy. The review of diabetic studies, 12 (1–2), 119–133.
- Feliers, D., and Kasinath, B.S., 2011. Erk in kidney diseases. Journal of signal transduction, 2011, 768512.
- Fineberg, D., Jandeleit-Dahm, K.A.M., and Cooper, M.E., 2013. Diabetic nephropathy: diagnosis and treatment. Nature reviews endocrinology, 9 (12), 713–723.
- Haller, H., et al., 2017. Molecular mechanisms and treatment strategies in diabetic nephropathy: new avenues for calcium dobesilate-free radical scavenger and growth factor inhibition. BioMed research international, 2017, 1909258.
- Khanra, R., et al., 2015. Abroma augusta L. (Malvaceae) leaf extract attenuates diabetes induced nephropathy and cardiomyopathy via inhibition of oxidative stress and inflammatory response. Journal of translational medicine, 13 (1), 6.
- Kim, J.M., et al., 2006. Dietary S-allyl-L-cysteine reduces mortality with decreased incidence of stroke and behavioral changes in stroke-prone spontaneously hypertensive rats. Bioscience, biotechnology, and biochemistry, 70 (8), 1969–1971.
- Kolset, S.O., Reinholt, F.P., and Jenssen, T., 2012. Diabetic nephropathy and extracellular matrix. The journal of histochemistry and cytochemistry: official journal of the histochemistry society, 60 (12), 976–986.
- Kuo, C.W., et al., 2015. Extracellular superoxide dismutase ameliorates streptozotocin-induced rat diabetic nephropathy via inhibiting the ROS/ERK1/2 signaling. Life sciences, 135, 77–86.
- Lagies, S., et al., 2019. Impact of diabetic stress conditions on renal cell metabolome. Cells, 8, 1141.
- Leib, D.E., Zimmerman, C.A., and Knight, Z.A., 2016. Thirst. Current biology, 26 (24), R1260–1265.
- Muhammad, N.O., et al., 2012. Haematological parameters of alloxan-induced diabetic rats treated with leaf essential oil of Hoslundia opposita (Vahl). EXCLI journal, 11, 670–676.
- Nazir, N., et al., 2014. Meta-analysis of diabetic nephropathy associated genetic variants in inflammation and angiogenesis involved in different biochemical pathways. BMC medical genetics, 15, 103.
- Oyedemi, S.O., Yakubu, M.T., and Afolayan, A.J., 2010. Effect of aqueous extract of Leonotis leonurus (L) R. Br leaves in male Wistar rats. Human & experimental toxicology, 29 (5), 377–384.
- Saravanan, G., et al., 2009. Antidiabetic properties of S-allylcysteine, a garlic component on streptozotocin-induced diabetes in rats. Journal of applied biomedicine, 7 (3), 151–159.
- Sathibabu Uddandrao, V.V., et al., 2019. Restorative potentiality of S-allylcysteine against diabetic nephropathy through attenuation of oxidative stress and inflammation in streptozotocin-nicotinamide-induced diabetic rats. European journal of nutrition, 58 (6), 2425–2437.
- Schwartz, M.W., et al., 2003. Is the energy homeostasis system inherently biased toward weight gain? Diabetes, 52 (2), 232–238.
- Sedeek, M., et al., 2013. Renoprotective effects of a novel Nox1/4 inhibitor in a mouse model of type 2 diabetes. Clinical science, 124 (3), 191–202.
- Soma, P., and Pretorius, E., 2015. Interplay between ultrastructural findings and atherothrombotic complications in type 2 diabetes mellitus. Cardiovascular diabetology, 14, 96.
- Srinivasan, K., and Ramarao, P., 2007. Animal models in type 2 diabetes research: an overview. The indian journal of medical research, 125 (3), 451–472.
- Sulaiman, M.K., 2019. Diabetic nephropathy: recent advances in pathophysiology and challenges in dietary management. Diabetology & metabolic syndrome, 11, 7.
- Tahmasebpour, N., et al., 2013. Variation in body weight and some hematological parameters in streptozotocin-induced diabetic rats, treated with Teucrium orientale. Pharmacology, 3, 32–36.
- Torel, J., Cillard, J., and Cillard, P., 1986. Antioxidant activity of flavonoids and reactivity with peroxy radical. Phytochemistry, 25 (2), 383–385.
- Wang-Fischer, Y., and Garyantes, T., 2018. Improving the reliability and utility of streptozotocin-induced rat diabetic model. Journal of diabetes research, 2018, 8054073.
- Wolf, G., and Ziyadeh, F.N., 2007. Cellular and molecular mechanisms of proteinuria in diabetic nephropathy. Nephron physiology, 106 (2), 26–31.
- Zafar, M., et al., 2009. Altered liver morphology and enzymes in streptozotocin induced diabetic rats. International journal of morphology, 27 (3), 719–725.
- Zeni, L., et al., 2017. A more tubulocentric view of diabetic kidney disease. Journal of nephrology, 30 (6), 701–717.
- Zhang, X.X., Kong, J., and Yun, K., 2020. Prevalence of diabetic nephropathy among patients with type 2 diabetes mellitus in China: a meta-analysis of observational studies. Journal of diabetes research, 2020, 1–11.